Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company's Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Healthcare Facilities & Services - NEC
- Sub-Industry: N/A
- Symbol: NYSE:FMS
- CUSIP: N/A
- Web: www.fmc-ag.com
Capitalization:- Market Cap: $28.94 billion
- Outstanding Shares: 613,722,000
Average Prices:- 50 Day Moving Avg: $47.26
- 200 Day Moving Avg: $45.06
- 52 Week Range: $38.05 - $50.22
P/E:- Trailing P/E Ratio: 20.63
- Foreward P/E Ratio: 18.42
- P/E Growth: 1.95
Sales & Book Value:- Annual Revenue: $20.17 billion
- Price / Sales: 1.43
- Book Value: $18.51 per share
- Price / Book: 2.55
Dividend:- Annual Dividend: $0.37
- Dividend Yield: 1.1%
Profitability:- EBIDTA: $3.68 billion
- Net Margins: 7.06%
- Return on Equity: 11.57%
- Return on Assets: 4.97%
Debt:- Debt-to-Equity Ratio: 0.60%
- Current Ratio: 1.27%
- Quick Ratio: 1.03%
Misc:- Average Volume: 145,906 shs.
- Beta: 0.47
- Short Ratio: 6.94
Frequently Asked Questions for Fresenius Medical Care Corporation (NYSE:FMS)
What is Fresenius Medical Care Corporation's stock symbol?
Fresenius Medical Care Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "FMS."
How often does Fresenius Medical Care Corporation pay dividends? What is the dividend yield for Fresenius Medical Care Corporation?
Fresenius Medical Care Corporation announced an annual dividend on Monday, April 24th. Shareholders of record on Monday, May 15th will be given a dividend of $0.5137 per share on Friday, May 26th. This represents a yield of 1.17%. The ex-dividend date of this dividend is Thursday, May 11th. View Fresenius Medical Care Corporation's Dividend History.
How were Fresenius Medical Care Corporation's earnings last quarter?
Fresenius Medical Care Corporation (NYSE:FMS) issued its quarterly earnings data on Tuesday, August, 1st. The company reported $0.48 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.53 by $0.05. The business earned $4.47 billion during the quarter, compared to analyst estimates of $5.20 billion. Fresenius Medical Care Corporation had a return on equity of 11.57% and a net margin of 7.06%. The firm's quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.96 EPS. View Fresenius Medical Care Corporation's Earnings History.
When will Fresenius Medical Care Corporation make its next earnings announcement?
Where is Fresenius Medical Care Corporation's stock going? Where will Fresenius Medical Care Corporation's stock price be in 2017?
10 brokers have issued 12 month target prices for Fresenius Medical Care Corporation's stock. Their forecasts range from $44.00 to $48.00. On average, they expect Fresenius Medical Care Corporation's stock price to reach $46.00 in the next twelve months. View Analyst Ratings for Fresenius Medical Care Corporation.
Are investors shorting Fresenius Medical Care Corporation?
Fresenius Medical Care Corporation saw a drop in short interest in July. As of July 31st, there was short interest totalling 389,571 shares, a drop of 42.0% from the July 14th total of 672,083 shares. Based on an average daily volume of 172,583 shares, the days-to-cover ratio is presently 2.3 days.
Who are some of Fresenius Medical Care Corporation's key competitors?
Some companies that are related to Fresenius Medical Care Corporation include HCA Holdings (HCA), Laboratory Corp. of America Holdings (LH), Quest Diagnostics Incorporated (DGX), DaVita HealthCare Partners (DVA), Universal Health Services (UHS), NMC Health PLC (NMC), HealthSouth Corporation (HLS), Acadia Healthcare Company (ACHC), Mednax (MD), Molina Healthcare (MOH), Chemed (CHE), LifePoint Health (LPNT), Select Medical Holdings Corporation (SEM), Udg Healthcare PLC (UDG), Tenet Healthcare Corporation (THC), China Cord Blood Corporation (CO), HMS Holdings Corp (HMSY) and Community Health Systems (CYH).
Who are Fresenius Medical Care Corporation's key executives?
Fresenius Medical Care Corporation's management team includes the folowing people:
- Gerd Krick, Chairman of the Supervisory Board
- Rice Powell, Chairman of the Management Board, Chief Executive Officer
- Dieter Schenk, Vice Chairman of the Supervisory Board
- Michael Brosnan, Chief Financial Officer, Member of the Management Board
- Harry De Wit, Chief Executive Officer for Asia-Pacific, Member of the Management Board
- Olaf Schermeier, Chief Executive Officer for Global Research and Development, Member of the Management Board
- William Valle, Chief Executive Officer for North America, Member of the Management Board
- Kent Wanzek, Chief Executive Officer for Global Manufacturing & Quality, Member of the Management Board
- Dominik Wehner, Chief Executive Officer for Europe, Middle East and Africa (EMEA), Member of the Management Board
- Ben J. Lipps, Honorary Chairman
Who owns Fresenius Medical Care Corporation stock?
Fresenius Medical Care Corporation's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Harding Loevner LP (0.61%), Cambiar Investors LLC (0.42%), Northern Trust Corp (0.15%), Marathon Asset Management LLP (0.10%), Royal Bank of Canada (0.08%) and US Bancorp DE (0.07%). View Institutional Ownership Trends for Fresenius Medical Care Corporation.
Who sold Fresenius Medical Care Corporation stock? Who is selling Fresenius Medical Care Corporation stock?
Fresenius Medical Care Corporation's stock was sold by a variety of institutional investors in the last quarter, including Manning & Napier Advisors LLC, Boston Partners, Wells Fargo & Company MN, JPMorgan Chase & Co., William Blair Investment Management LLC, Citadel Advisors LLC, People s United Financial Inc. and Northern Trust Corp. View Insider Buying and Selling for Fresenius Medical Care Corporation.
Who bought Fresenius Medical Care Corporation stock? Who is buying Fresenius Medical Care Corporation stock?
Fresenius Medical Care Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Harding Loevner LP, Cambiar Investors LLC, Harbour Capital Advisors LLC, OxFORD Asset Management LLP, Ativo Capital Management LLC, US Bancorp DE, Kayne Anderson Rudnick Investment Management LLC and Parametric Portfolio Associates LLC. View Insider Buying and Selling for Fresenius Medical Care Corporation.
How do I buy Fresenius Medical Care Corporation stock?
Shares of Fresenius Medical Care Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Fresenius Medical Care Corporation's stock price today?
One share of Fresenius Medical Care Corporation stock can currently be purchased for approximately $47.15.
MarketBeat Community Rating for Fresenius Medical Care Corporation (NYSE FMS)MarketBeat's community ratings are surveys of what our community members think about Fresenius Medical Care Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Fresenius Medical Care Corporation (NYSE:FMS) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 7 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.70) |
| Consensus Price Target: | $46.00 (2.44% downside) |
Analysts' Ratings History for Fresenius Medical Care Corporation (NYSE:FMS)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 8/8/2017 | Royal Bank Of Canada | Reiterated Rating | Neutral | | Low |  |
| 8/7/2017 | DZ Bank AG | Reiterated Rating | Buy | | Medium | |
| 6/28/2017 | Nord/LB | Reiterated Rating | Buy | | Low | |
| 3/12/2017 | Sanford C. Bernstein | Reiterated Rating | Buy | | Low | |
| 2/24/2017 | Societe Generale | Downgrade | Buy -> Hold | | N/A | |
| 12/14/2016 | J P Morgan Chase & Co | Reiterated Rating | Buy | | N/A | |
| 10/18/2016 | HSBC Holdings plc | Reiterated Rating | Hold | | N/A | |
| 10/18/2016 | Citigroup Inc. | Reiterated Rating | Buy | | N/A | |
| 10/13/2016 | SunTrust Banks, Inc. | Set Price Target | Buy | $48.00 | N/A | |
| 9/21/2016 | Goldman Sachs Group, Inc. (The) | Reiterated Rating | Buy | | N/A | |
| 8/9/2016 | Berenberg Bank | Reiterated Rating | Buy | | N/A | |
| 7/8/2016 | Jefferies Group LLC | Upgrade | Underperform -> Hold | | N/A | |
| 5/16/2016 | Robert W. Baird | Reiterated Rating | Hold | | N/A | |
| 3/17/2016 | Nomura | Initiated Coverage | Buy | | N/A | |
| 11/9/2015 | Barclays PLC | Downgrade | Equal Weight -> Underweight | | N/A | |
| 10/30/2015 | Piper Jaffray Companies | Reiterated Rating | Hold | $41.00 -> $43.00 | N/A | |
(Data available from 8/24/2015 forward)
Earnings History for Fresenius Medical Care Corporation (NYSE:FMS)Earnings History by Quarter for Fresenius Medical Care Corporation (NYSE FMS)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/26/2017 | | | | | | | | |
| 8/1/2017 | 6/30/2017 | $0.53 | $0.48 | $5.20 billion | $4.47 billion | View | Listen | |
| 5/3/2017 | Q2 | $0.44 | $0.53 | $4.69 billion | $4.55 billion | View | Listen | |
| 2/22/2017 | Q416 | $0.62 | $0.63 | $4.74 billion | $4.69 billion | View | Listen | |
| 10/27/2016 | Q316 | $0.52 | $0.54 | $4.55 billion | $4.60 billion | View | Listen | |
| 8/1/2016 | Q216 | $0.49 | $0.48 | $4.54 billion | $4.42 billion | View | N/A | |
| 5/3/2016 | Q116 | $0.42 | $0.37 | $4.25 billion | $4.21 billion | View | N/A | |
| 2/24/2016 | Q415 | $0.58 | $0.52 | $4.41 million | $4.35 million | View | Listen | |
| 10/29/2015 | Q3 | $0.45 | $0.43 | $4.27 billion | $4.23 billion | View | Listen | |
| 7/30/2015 | Q215 | $0.42 | $0.40 | $4.13 billion | $4.20 billion | View | Listen | |
| 4/30/2015 | Q1 | $0.40 | $0.35 | $3.89 billion | $3.96 billion | View | N/A | |
| 2/25/2015 | Q4 | $0.49 | $0.56 | $4.23 billion | $4.32 billion | View | N/A | |
| 11/4/2014 | Q3 | $0.44 | $0.45 | $3.94 billion | $4.11 billion | View | N/A | |
| 7/31/2014 | Q2 | $0.41 | $0.39 | | $3.84 billion | View | N/A | |
| 5/6/2014 | Q1 2014 | $0.38 | $0.34 | $3.60 billion | $3.56 billion | View | N/A | |
| 2/25/2014 | Q4 | $0.53 | $0.58 | | | View | N/A | |
| 11/5/2013 | | $0.45 | $0.47 | | | View | N/A | |
| 7/30/2013 | | $0.46 | $0.43 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Fresenius Medical Care Corporation (NYSE:FMS)2017 EPS Consensus Estimate: $2.11
2018 EPS Consensus Estimate: $2.58
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.44 | $0.44 | $0.44 |
| Q2 2017 | 1 | $0.54 | $0.54 | $0.54 |
| Q3 2017 | 1 | $0.56 | $0.56 | $0.56 |
| Q4 2017 | 1 | $0.57 | $0.57 | $0.57 |
| Q1 2018 | 1 | $0.61 | $0.61 | $0.61 |
| Q2 2018 | 1 | $0.64 | $0.64 | $0.64 |
| Q3 2018 | 1 | $0.66 | $0.66 | $0.66 |
| Q4 2018 | 1 | $0.67 | $0.67 | $0.67 |
(Data provided by Zacks Investment Research)
Current Dividend Information for Fresenius Medical Care Corporation (NYSE:FMS)| Most Recent Dividend: | 5/26/2017 |
| Annual Dividend: | $0.37 |
| Dividend Yield: | 0.78% |
| Dividend Growth: | -2.10% (3 Year Average) |
| Payout Ratio: | 16.97% (Trailing 12 Months of Earnings)
15.88% (Based on This Year's Estimates)
14.45% (Based on Next Year's Estimates)
|
Dividend History by Quarter for Fresenius Medical Care Corporation (NYSE FMS)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 4/24/2017 | annual | $0.51 | 1.17% | 5/11/2017 | 5/15/2017 | 5/26/2017 |
| 3/9/2016 | | $0.30 | | 5/10/2016 | 5/12/2016 | 5/23/2016 |
| 5/2/2014 | annual | $0.53 | 1.57% | 5/13/2014 | 5/15/2014 | 5/27/2014 |
| 5/14/2013 | annual | $0.49 | 1.42% | 5/14/2013 | 5/16/2013 | 5/28/2013 |
(Data available from 1/1/2013 forward)
Insider Trading History for Fresenius Medical Care Corporation (NYSE:FMS)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Fresenius Medical Care Corporation (NYSE:FMS)
Latest Headlines for Fresenius Medical Care Corporation (NYSE:FMS)
| Source: |
|
| Date | Headline |
|---|
 | Fresenius Medical Care Corporation (FMS) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - August 18 at 8:56 PM |
 | EMEA and APAC: Fresenius Medical Care’s Dialysis Products Business
finance.yahoo.com - August 18 at 6:36 PM |
| Fresenius Medical Care Is a Global Leader in the Dialysis Segment
finance.yahoo.com - August 18 at 6:36 PM |
| Short Interest in Fresenius Medical Care Corporation (FMS) Declines By 42.0%
www.americanbankingnews.com - August 17 at 3:44 AM |
| Fresenius Medical Care Corporation (FMS) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - August 16 at 3:48 PM |
| $5.13 Billion in Sales Expected for Fresenius Medical Care Corporation (FMS) This Quarter
www.americanbankingnews.com - August 14 at 9:52 AM |
| $0.58 Earnings Per Share Expected for Fresenius Medical Care Corporation (NYSE:FMS) This Quarter
www.americanbankingnews.com - August 12 at 6:12 AM |
| NxStage (NXTM) Jumps 28% on $2 Billion Acquisition by FMS
finance.yahoo.com - August 9 at 11:58 PM |
| Corporate News Blog - Fresenius Medical Care to Acquire NxStage Medical to Strengthen Its Vertically Integrated Dialysis Business
finance.yahoo.com - August 9 at 6:57 PM |
| NxStage Medical Acquired by Fresenius for $2 Billion
finance.yahoo.com - August 7 at 9:13 PM |
| [$$] Fresenius Medical Care agrees $2bn deal to buy NxStage
finance.yahoo.com - August 7 at 9:13 PM |
| NxStage (NXTM) Jumps 28% on $2 Billion Acquisition by FMS
finance.yahoo.com - August 7 at 9:13 PM |
| Fresenius Medical Care AG & Co. KGaA :FMS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 7, 2017
finance.yahoo.com - August 7 at 9:13 PM |
| Buyout Bid Overshadows NxStage Medical's Losses
finance.yahoo.com - August 7 at 9:13 PM |
 | Fresenius Medical Care (FMS) to Acquire NxStage Medical (NXTM) for $30/Sh; Transaction Valued at $2B
www.streetinsider.com - August 7 at 4:13 PM |
| Fresenius Medical Care Corporation (NYSE:FMS) Stock Rating Reaffirmed by DZ Bank AG
www.americanbankingnews.com - August 7 at 11:46 AM |
 | Fresenius Medical Care To Buy NxStage Medical In $2 Bln Deal - Quick Facts
www.rttnews.com - August 7 at 3:37 AM |
| Germany's FMC to buy U.S. home dialysis firm NxStage for $2 bln
finance.yahoo.com - August 7 at 3:37 AM |
| Fresenius Medical Care to Acquire NxStage Medical, Inc. to Strengthen Its Vertically Integrated Dialysis Business
finance.yahoo.com - August 7 at 3:37 AM |
| Jefferies Group Weighs in on Fresenius Medical Care Corporation's FY2017 Earnings (FMS)
www.americanbankingnews.com - August 4 at 11:10 AM |
| SunTrust Banks Equities Analysts Increase Earnings Estimates for Fresenius Medical Care Corporation (NYSE:FMS)
www.americanbankingnews.com - August 4 at 11:08 AM |
 | Fresenius Medical Care Enters Oversold Territory
www.nasdaq.com - August 2 at 7:35 PM |
| Fresenius Medical Care Corporation (FMS) Announces Quarterly Earnings Results
www.americanbankingnews.com - August 2 at 7:06 PM |
 | Fresenius Medical Care AG & Co. KGaA (FMS) Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 1 at 7:20 PM |
| Fresenius Medical Care Corporation's (FMS) Neutral Rating Reaffirmed at Royal Bank Of Canada
www.americanbankingnews.com - August 1 at 12:56 PM |
| Fresenius Medical Care Q2 EBIT Rises; Confirms 2017 Outlook
www.rttnews.com - August 1 at 4:30 AM |
| Fresenius Medical Care Corporation (FMS) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 27 at 11:12 AM |
| Fresenius Medical Care Corporation (NYSE:FMS) Expected to Announce Quarterly Sales of $4.79 Billion
www.americanbankingnews.com - July 26 at 10:40 AM |
| $0.53 Earnings Per Share Expected for Fresenius Medical Care Corporation (FMS) This Quarter
www.americanbankingnews.com - July 25 at 12:26 AM |
| Fresenius Medical Care Corporation (FMS) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - July 24 at 9:04 PM |
 | Fresenius Medical Care North America Receives Safety In Excellence Award From ...
www.prnewswire.com - July 19 at 7:25 PM |
| Fresenius Medical Care Refinances Existing Senior Secure Credit Deal
www.nasdaq.com - July 12 at 7:28 PM |
| William McKinney, Fresenius Medical Care North America, Named Chair of Austin Kidney Walk
finance.yahoo.com - July 12 at 7:28 PM |
| ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : July 12, 2017
finance.yahoo.com - July 12 at 7:28 PM |
| Fresenius Medical Care Holdings, Inc. -- Moody's upgrades FMCH's long term issuer rating to Baa3, outlook stable
finance.yahoo.com - July 8 at 10:50 AM |
| Fresenius Medical Care Corporation (NYSE:FMS) Stock Rating Reaffirmed by Royal Bank Of Canada
www.americanbankingnews.com - July 5 at 9:20 PM |
| Fresenius Medical Care Corporation (NYSE:FMS) Rating Reiterated by Nord/LB
www.americanbankingnews.com - July 2 at 1:56 PM |
| Zacks: Analysts Anticipate Fresenius Medical Care Corporation (FMS) Will Post Quarterly Sales of $4.79 Billion
www.americanbankingnews.com - June 30 at 11:56 AM |
| Fresenius Medical Care Corporation (FMS) Expected to Announce Earnings of $0.52 Per Share
www.americanbankingnews.com - June 28 at 8:14 PM |
| Fresenius Medical Care Corporation (FMS) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 27 at 6:40 PM |
| Frenova Renal Research Announces Expansion of F1RST Up™ (Frenova Rapid STart Up) Alliance of Investigative Sites Designed to Speed Clinical Trial Initiation
finance.yahoo.com - June 20 at 5:56 PM |
| Jefferies Group Research Analysts Raise Earnings Estimates for Fresenius Medical Care Corporation (FMS)
www.americanbankingnews.com - June 19 at 7:20 AM |
| ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : June 9, 2017
finance.yahoo.com - June 9 at 5:40 PM |
| Financial Review: Cancer Genetics (CGIX) vs. Fresenius Medical Care AG & Co. (FMS)
www.americanbankingnews.com - June 8 at 10:20 PM |
| Fresenius Medical Care AG & Co (FMS) Investor Presentation - Slideshow
seekingalpha.com - June 8 at 6:14 PM |
| $4.79 Billion in Sales Expected for Fresenius Medical Care AG & Co. (FMS) This Quarter
www.americanbankingnews.com - June 4 at 7:54 AM |
| Zacks: Brokerages Anticipate Fresenius Medical Care AG & Co. (FMS) Will Announce Earnings of $0.52 Per Share
www.americanbankingnews.com - June 2 at 6:22 PM |
| Fresenius Medical Care AG & Co. (FMS) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - June 2 at 10:28 AM |
| Royal Bank of Canada Reaffirms Hold Rating for Fresenius Medical Care AG & Co. (FMS)
www.americanbankingnews.com - May 30 at 9:32 PM |
| ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : May 30, 2017
finance.yahoo.com - May 30 at 5:12 PM |
Fresenius Medical Care Corporation (FMS) Chart for Thursday, August, 24, 2017
